⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23910 | 0.94 | HSD17B10 (0.33) | — | |
| SCHEMBL539196 | 0.82 | — | — | |
| SCHEMBL2902805 | 0.80 | — | — | |
| SCHEMBL939722 | 0.80 | MEN1 (0.32) | — | |
| SCHEMBL2255927 | 0.79 | — | — | |
| SCHEMBL4302940 | 0.78 | HTT (0.48) | — | |
| SCHEMBL6938921 | 0.78 | HTT (0.48) | — | |
| SCHEMBL1609595 | 0.78 | HTT (0.48) | — | |
| SCHEMBL6936434 | 0.78 | HTT (0.48) | — | |
| SCHEMBL6939366 | 0.78 | HTT (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 281 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210100246-A1 | PYRIDYL-FORMAMIDINES HAVING A FUNGICIDAL ACTIVITY, THEIR AGRONOMIC COMPOSITIONS AND USE THEREOF | BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT | 2021-04-08 | — | — | US | claimed |
| EP-2283085-B1 | WATER- BASED COATING COMPOSITION CONTAINING DIALKYL CARBONATES HAVING ETHER FUNCTIONS AS COALESCENT AGENTS AND USE THEROF | LECHLER S P A (IT) | 2013-02-13 | — | — | EP | claimed |
| US-8222398-B2 | Chimeric immunomodulatory compounds and methods of using the same-II | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2012-07-17 | — | — | US | claimed |
| CN-1809570-B | [1,2,4] triazolo [1,5-a ] pyrimidin-2-ylurea derivatives and uses thereof | NIPPON KAYAKU KK | 2011-06-22 | — | — | CN | claimed |
| CN-101003499-B | Novel color former and recording material | ASAHI CHEMICAL IND | 2011-01-19 | — | — | CN | claimed |
| EP-1630165-B1 | [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF | NIPPON KAYAKU KK (JP) | 2010-03-31 | — | — | EP | claimed |
| US-20090317480-A1 | CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME-II | DYNAVAX TECHNOLOGIES CORPORATION | 2009-12-24 | — | — | US | claimed |
| US-7598244-B2 | [1,2,4]triazolo[1,5,a]pyrimidin-2-ylurea derivative and use thereof | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-10-06 | — | — | US | claimed |
| US-7465728-B2 | Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity | ASTRAZENECA AB (SE) | 2008-12-16 | — | — | US | claimed |
| US-20070010515-A1 | [1,2,4] Triazolo [1,5, a] pyrimidin-2-ylurea derivative and use thereof | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2007-01-11 | — | — | US | claimed |
| EP-1630165-A1 | [1,2,4 ]TRIAZOLO [1,5-A]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF | Nippon Kayaku Kabushiki Kaisha (JP) | 2006-03-01 | — | — | EP | claimed |
| US-20050131000-A1 | Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity | ASTRAZENECA AB (SE) | 2005-06-16 | — | — | US | claimed |
| EP-1487823-A1 | DERIVATIVES OF 4-(IMIDAZOL-5-YL)-2-(4-SULFOANILINO)PYRIMIDINE WITH CDK INHIBITORY ACTIVITY | AstraZeneca AB (SE) | 2004-12-22 | — | — | EP | claimed |
| EP-1144102-B1 | CONCENTRATED OR DILUTABLE SOLUTIONS OR DISPERSIONS AND PREPARATION METHOD | ARCANE IND (FR) | 2004-04-07 | — | — | EP | claimed |
| US-20030191306-A1 | Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | G.D. SEARLE & CO. (US) | 2003-10-09 | — | — | US | claimed |
| WO-2003076436-A1 | DERIVATIVES OF 4- (IMIDAZOL-5-YL)-2-(4-SULFOANILINO) PYRIMIDINE WITH CDK INHIBITORY ACTIVITY | ASTRAZENECA AB (SE) | 2003-09-18 | — | — | WO | claimed |
| US-20010018446-A1 | Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | G.D. SEARLE & CO. (US) | 2001-08-30 | — | — | US | claimed |
| US-6017676-A | Photoresist composition comprising a copolymer resin | HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) | 2000-01-25 | — | — | US | claimed |
| EP-0512404-A1 | Identification of liquid hydrocarbons using chemical markers | NALCO CHEMICAL COMPANY (US) | 1992-11-11 | — | — | EP | claimed |
| CN-118215886-A | Composition for forming alkoxy group-containing resist underlayer film | 日产化学株式会社 | 2024-06-18 | — | — | CN | disclosed |
| CN-118202304-A | Composition for forming resist underlayer film containing acrylamide group | 日产化学株式会社 | 2024-06-14 | — | — | CN | disclosed |
| CN-118184730-A | Polycyclic compounds and their use as ghrelin receptor agonists | 南京知和医药科技有限公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-118119567-A | Hydrophobic organic solvent-dispersed silica sol and method for producing same | 日产化学株式会社 | 2024-05-31 | — | — | CN | disclosed |
| CN-118076561-A | Ester-dispersed silica sol and method for producing same | 日产化学株式会社 | 2024-05-24 | — | — | CN | disclosed |
| CN-112771130-B | Ink composition | 日产化学株式会社 | 2024-03-29 | — | — | CN | disclosed |
| CN-117736193-A | Deuterated condensed ring compound and preparation method and application thereof | 南京知和医药科技有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-115960080-B | Polycyclic compounds and their use as ghrelin receptor agonists | 南京知和医药科技有限公司 | 2024-03-15 | — | — | CN | disclosed |
| US-20240000767-A1 | COMBINATION OF AN ALPHA2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONIST WITH A TASK1/3 CHANNEL BLOCKER FOR THE TREATMENT OF SLEEP APNEA | BAYER AKTIENGESELLSCHAFT (DE) | 2024-01-04 | — | — | US | disclosed |
| CN-117209539-A | Polycyclic compound and preparation method and application thereof | 南京知和医药科技有限公司 | 2023-12-12 | — | — | CN | disclosed |
| CN-115925699-B | Fused ring compound with analgesic activity and preparation method and application thereof | 南京知和医药科技有限公司 | 2023-10-03 | — | — | CN | disclosed |
| WO-2023176458-A1 | DISINFECTING COMPOSITION CONTAINING THIAZOLE CARBOXYLIC ACID HYDRAZIDE COMPOUND | 石原産業株式会社 | 2023-09-21 | — | — | WO | disclosed |
| CN-116768908-A | N-containing polycyclic compound and preparation method and application thereof | 石家庄迪斯凯威医药科技有限公司 | 2023-09-19 | — | — | CN | disclosed |
| CN-116751186-A | Preparation and application of estrogen receptor modulator | 南京知和医药科技有限公司 | 2023-09-15 | — | — | CN | disclosed |
| WO-2023160004-A1 | FUSED-RING COMPOUND HAVING ANALGESIC ACTIVITY, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 南京知和医药科技有限公司 | 2023-08-31 | — | — | WO | disclosed |
| WO-2023131638-A1 | 2,3-DIHYDROBENZO [B][1, 4]DIOXIN-2-YLMETHYL)PIPERAZIN-1-YL DERIVATES FOR THE TREATMENT OF SLEEP APNEA | BAYER AKTIENGESELLSCHAFT (DE) | 2023-07-13 | — | — | WO | disclosed |
| WO-2023131640-A1 | α2-ADRENOCEPTOR SUBTYPE C ANTAGONISTS FOR THE TREATMENT OF SLEEP APNEA | BAYER AKTIENGESELLSCHAFT (DE) | 2023-07-13 | — | — | WO | disclosed |
| WO-2023118122-A1 | COMBINATION OF A TASK1/3 CHANNEL BLOCKER WITH A P2X3 RECEPTOR ANTAGONIST FOR THE TREATMENT OF SLEEP APNEA | BAYER AKTIENGESELLSCHAFT (DE) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023118126-A1 | COMBINATION OF A TASK1/3 CHANNEL BLOCKER WITH A NOREPINEPHRINE REUPTAKE INHIBITOR FOR THE TREATMENT OF SLEEP APNEA | BAYER AKTIENGESELLSCHAFT (DE) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023118102-A1 | COMBINATION OF A TASK1/3 CHANNEL BLOCKER WITH A MUSCARINIC RECEPTOR ANTAGONIST FOR THE TREATMENT OF SLEEP APNEA | BAYER AKTIENGESELLSCHAFT (DE) | 2023-06-29 | — | — | WO | disclosed |
| US-20230192919-A1 | DISPERSION COMPOSITION | NIPPON PAPER INDUSTRIES CO., LTD. (JP) | 2023-06-22 | — | — | US | disclosed |
| WO-2023106377-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | 旭化成株式会社 | 2023-06-15 | — | — | WO | disclosed |
| WO-2023085295-A1 | COMPOSITION FOR FORMING ALKOXY GROUP-CONTAINING RESIST UNDERLAYER FILM | 日産化学株式会社 | 2023-05-19 | — | — | WO | disclosed |
| WO-2023085293-A1 | COMPOSITION FOR FORMING ACRYLAMIDE GROUP-CONTAINING RESIST UNDERLAYER FILM | 日産化学株式会社 | 2023-05-19 | — | — | WO | disclosed |
| EP-4175954-A1 | COMBINATION OF AN ALPHA2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONIST WITH A TASK1/3 CHANNEL BLOCKER FOR THE TREATMENT OF SLEEP APNEA | Bayer Aktiengesellschaft (DE) | 2023-05-10 | — | — | EP | disclosed |
| CN-116082437-A | Polycyclic compounds and their use as ghrelin receptor agonists | 石家庄迪斯凯威医药科技有限公司 | 2023-05-09 | — | — | CN | disclosed |
| CN-116057057-A | Conjugates of alpha 2-adrenoceptor subtype C (alpha-2C) antagonists and TASK1/3 channel blockers for the treatment of sleep apnea | 拜耳公司 | 2023-05-02 | — | — | CN | disclosed |
| EP-4166583-A1 | DISPERSION COMPOSITION | Nippon Paper Industries Co., Ltd. (JP) | 2023-04-19 | — | — | EP | disclosed |
| CN-115960080-A | Polycyclic compound and application thereof as ghrelin receptor agonist | 南京知和医药科技有限公司 | 2023-04-14 | — | — | CN | disclosed |
| CN-115925699-A | Condensed ring compound with analgesic activity and preparation method and application thereof | 南京知和医药科技有限公司 | 2023-04-07 | — | — | CN | disclosed |
| WO-2023013503-A1 | ESTER-DISPERSED SILICA SOL AND PRODUCTION METHOD THEREFOR | 日産化学株式会社 | 2023-02-09 | — | — | WO | disclosed |
| WO-2023013504-A1 | HYDROPHOBIC ORGANIC SOLVENT-DISPERSED SILICA SOL AND METHOD FOR PRODUCING SAME | 日産化学株式会社 | 2023-02-09 | — | — | WO | disclosed |
| WO-2023008020-A1 | DISPERSION COMPOSITION | 日本製紙株式会社 | 2023-02-02 | — | — | WO | disclosed |
| CN-115667396-A | Dispersion composition | 日本制纸株式会社 | 2023-01-31 | — | — | CN | disclosed |
| CN-110235264-B | Ink composition containing sulfonated conjugated polymer | 日产化学株式会社 | 2022-08-23 | — | — | CN | disclosed |
| US-20220218700-A1 | COMBINATION OF AN ?2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS WITH A TASK1/3 CHANNEL BLOCKER FOR THE TREATMENT OF SLEEP APNEA | BAYER AKTIENGESELLSCHAFT (DE) | 2022-07-14 | — | — | US | disclosed |
| US-20220218695-A1 | COMBINATION OF AN ALPHA2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS WITH A TASK1/3 CHANNEL BLOCKER FOR THE TREATMENT OF SLEEP APNEA | BAYER AKTIENGESELLSCHAFT (DE) | 2022-07-14 | — | — | US | disclosed |
| CN-110268540-B | Ink composition | 日产化学株式会社 | 2022-07-01 | — | — | CN | disclosed |
| US-20220209301-A1 | CARBONATE SOLVENTS FOR NON-AQUEOUS ELECTROLYTES FOR METAL AND METAL-ION BATTERIES | SCE FRANCE (FR) | 2022-06-30 | — | — | US | disclosed |
| EP-3965762-A1 | COMBINATION OF AN ?2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS WITH A TASK1/3 CHANNEL BLOCKER FOR THE TREATMENT OF SLEEP APNEA | Bayer Aktiengesellschaft (DE) | 2022-03-16 | — | — | EP | disclosed |
| EP-3956288-A1 | CARBONATE SOLVENTS FOR NON-AQUEOUS ELECTROLYTES FOR METAL AND METAL-ION BATTERIES | SCE France (FR) | 2022-02-23 | — | — | EP | disclosed |
| WO-2022008426-A1 | COMBINATION OF AN ALPHA2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONIST WITH A TASK1/3 CHANNEL BLOCKER FOR THE TREATMENT OF SLEEP APNEA | BAYER AKTIENGESELLSCHAFT (DE) | 2022-01-13 | — | — | WO | disclosed |
| CN-113795963-A | Carbonate solvents for non-aqueous electrolytes for metal and metal ion batteries | 斯塞法国公司 | 2021-12-14 | — | — | CN | disclosed |
| CN-107849376-B | Non-aqueous ink composition comprising metal nanoparticles suitable for organic electronics | 日产化学工业株式会社 | 2021-11-30 | — | — | CN | disclosed |
| US-20210338662-A1 | ALPHA-2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS FOR THE TREATMENT OF SLEEP APNEA | BAYER AKTIENGESELISCHAFT (DE) | 2021-11-04 | — | — | US | disclosed |
| CN-107406714-B | Composition containing hole carrier material and fluorine-containing polymer and use thereof | 日产化学工业株式会社 | 2021-09-28 | — | — | CN | disclosed |
| CN-108463517-B | Non-aqueous ink compositions comprising transition metal complexes and their use in organic electronics | 日产化学工业株式会社 | 2021-09-28 | — | — | CN | disclosed |
| CN-107709316-B | 2- (1-heteroarylpiperazin-4-yl) methyl-1, 4-benzodioxane derivatives as alpha 2C antagonists | 奥赖恩公司 | 2021-08-17 | — | — | CN | disclosed |
| EP-3122312-B1 | CORROSIVE INGREDIENT (S) - CONTAINING COMPOSITIONS HAVING REDUCED TOXICITY AND METHOD OF OBTAINING | JOHNSON & SON INC S C (US) | 2021-08-04 | — | — | EP | disclosed |
| CN-112771130-A | Ink composition | 日产化学株式会社 | 2021-05-07 | — | — | CN | disclosed |
| CN-112714647-A | Alpha 2-adrenoceptor subtype C (alpha-2C) antagonists for the treatment of sleep apnea | 拜耳公司 | 2021-04-27 | — | — | CN | disclosed |
| CN-108521834-B | Nanoparticle-conductive polymer composites for organic electronics | 日产化学工业株式会社 | 2021-04-23 | — | — | CN | disclosed |
| US-20210100246-A1 | PYRIDYL-FORMAMIDINES HAVING A FUNGICIDAL ACTIVITY, THEIR AGRONOMIC COMPOSITIONS AND USE THEREOF | BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT | 2021-04-08 | — | — | US | disclosed |
| CN-107531887-B | Compositions containing a hole carrier material and a poly (aryl ether sulfone) and uses thereof | 日产化学工业株式会社 | 2021-02-02 | — | — | CN | disclosed |
| WO-2020240400-A1 | PROCESSES FOR PRODUCING ORTHOESTERS FROM ORGANOSULFUR COMPOUNDS | SCE FRANCE (FR) | 2020-12-03 | — | — | WO | disclosed |
| WO-2020225185-A1 | COMBINATION OF AN α2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS WITH A TASK1/3 CHANNEL BLOCKER FOR THE TREATMENT OF SLEEP APNEA | BAYER AKTIENGESELLSCHAFT (DE) | 2020-11-12 | — | — | WO | disclosed |
| WO-2020225188-A1 | COMBINATION OF AN α2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS WITH A TASK1/3 CHANNEL BLOCKER FOR THE TREATMENT OF SLEEP APNEA | BAYER AKTIENGESELLSCHAFT (DE) | 2020-11-12 | — | — | WO | disclosed |
| WO-2020212872-A1 | CARBONATE SOLVENTS FOR NON-AQUEOUS ELECTROLYTES FOR METAL AND METAL-ION BATTERIES | SCE FRANCE (FR) | 2020-10-22 | — | — | WO | disclosed |
| US-10774074-B2 | 2-(1-heteroarylpiperazin-4-yl)methyl-1,4-benzodioxane derivatives as alpha2C antagonists | ORION CORPORATION (FI) | 2020-09-15 | — | — | US | disclosed |
| US-20200201183-A1 | RESIST UNDERLAYER FILM FORMING COMPOSITION CONTAINING COMPOUND HAVING HYDANTOIN RING | NISSAN CHEMICAL CORPORATION (JP) | 2020-06-25 | — | — | US | disclosed |
| EP-3303327-B1 | 2-(1-HETEROARYLPIPERAZIN-4-YL)METHYL-1,4-BENZODIOXANE DERIVATIVES AS ALPHA2C ANTAGONISTS | ORION CORP (FI) | 2020-03-11 | — | — | EP | disclosed |
| CN-110770307-A | Non-aqueous ink composition | 日产化学株式会社 | 2020-02-07 | — | — | CN | disclosed |
| US-20190292170-A9 | 2-(1-HETEROARYLPIPERAZIN-4-YL)METHYL-1,4-BENZODIOXANE DERIVATIVES AS ALPHA2C ANTAGONISTS | ORION CORPORATION (FI) | 2019-09-26 | — | — | US | disclosed |
| CN-106536652-B | Coating composition | 关西涂料株式会社 | 2019-08-16 | — | — | CN | disclosed |
| CN-104685976-B | The manufacturing method of conductive pattern | 东丽株式会社 | 2019-05-31 | — | — | CN | disclosed |
| US-20190152992-A1 | BENZODIOXANE DERIVATIVES AND THEIR PHARMACEUTICAL USE | ORION CORPORATION (FI) | 2019-05-23 | — | — | US | disclosed |
| EP-3478676-A1 | BENZODIOXANE DERIVATIVES AND THEIR PHARMACEUTICAL USE | Orion Corporation (FI) | 2019-05-08 | — | — | EP | disclosed |
| CN-106632507-B | Metal complex and preparation method thereof, and preparation method of olefin binary copolymer | 中国石油天然气股份有限公司 | 2019-03-12 | — | — | CN | disclosed |
| US-20180215739-A1 | 2-(1-HETEROARYLPIPERAZIN-4-YL)METHYL-1,4-BENZODIOXANE DERIVATIVES AS ALPHA2C ANTAGONISTS | ORION CORPORATION (FI) | 2018-08-02 | — | — | US | disclosed |
| CN-101721362-B | Pharmaceutical solutions comprising antibody | 中外制药株式会社 | 2018-07-03 | — | — | CN | disclosed |
| EP-2834233-B1 | NEW ALPHA2 ADRENOCEPTOR AGONISTS | ORION CORP (FI) | 2018-04-25 | — | — | EP | disclosed |
| EP-3303327-A1 | 2-(1-HETEROARYLPIPERAZIN-4-YL)METHYL-1,4-BENZODIOXANE DERIVATIVES AS ALPHA2C ANTAGONISTS | Orion Corporation (FI) | 2018-04-11 | — | — | EP | disclosed |
| US-20180057462-A1 | Substituted 2-difluoromethyl-nicotin(thio)carboxanilide derivatives and their use as fungicides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-03-01 | — | — | US | disclosed |
| WO-2018002437-A1 | BENZODIOXANE DERIVATIVES AND THEIR PHARMACEUTICAL USE | ORION CORPORATION (FI) | 2018-01-04 | — | — | WO | disclosed |
| US-9840495-B2 | Oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and use thereof for treating vasopressine-related diseases | AbbVie Deutschland GmbH & Co. KG (DE) | 2017-12-12 | — | — | US | disclosed |
| US-9700043-B2 | Corrosive ingredient(s)-containing compositions having reduced toxicity and method of obtaining | S. C. JOHNSON & SON, INC. (US) | 2017-07-11 | — | — | US | disclosed |
| CN-106632507-A | Metal complex and preparation method thereof, and preparation method of olefin binary copolymer | 中国石油天然气股份有限公司 | 2017-05-10 | — | — | CN | disclosed |
| EP-2903965-B1 | N-PROP-2-YNYL CARBOXAMIDE DERIVATIVES AND THEIR USE AS TRPA1 ANTAGONISTS | ORION CORP (FI) | 2017-03-01 | — | — | EP | disclosed |
| US-20170008875-A1 | OXINDOLE DERIVATIVES CARRYING A PIPERIDYL-SUBSTITUTED AZETIDINYL SUBSTITUENT AND USE THEREOF FOR TREATING VASOPRESSINE-RELATED DISEASES | AbbVie Deutschland GmbH & Co. KG (DE) | 2017-01-12 | — | — | US | disclosed |
| WO-2016193551-A1 | 2-(1-HETEROARYLPIPERAZIN-4-YL)METHYL-1,4-BENZODIOXANE DERIVATIVES AS ALPHA2C ANTAGONISTS | ORION CORPORATION (FI) | 2016-12-08 | — | — | WO | disclosed |
| CN-102731387-B | Salt for dye | 住友化学株式会社 | 2016-08-03 | — | — | CN | disclosed |
| WO-2016087593-A1 | NOVEL FUNGICIDAL QUINOLINYLAMIDINES | SYNGENTA PARTICIPATIONS AG (CH) | 2016-06-09 | — | — | WO | disclosed |
| CN-102884145-B | Pretreatment compositions | HEWLETT-PACKARD DEVELOPMENT CO.,L.P. (US) | 2016-04-13 | — | — | CN | disclosed |
| US-9249127-B2 | Alpha2 adrenoceptor agonists | ORION CORPORATION (FI) | 2016-02-02 | — | — | US | disclosed |
| CN-104024241-B | Uracil derivatives and their use for medical purposes | DAINIPPON SUMITOMO PHARMA CO.,LTD. (JP) | 2016-01-20 | — | — | CN | disclosed |
| CN-105198805-A | Compound and coloring curable resin composition | SUMITOMO CHEMICAL CO | 2015-12-30 | — | — | CN | disclosed |
| CN-102276589-B | Dye composition | SUMITOMO CHEMICAL CO., LTD. (JP) | 2015-11-25 | — | — | CN | disclosed |
| US-20150297737-A1 | CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME-IV | DYNAVAX TECHNOLOGIES CORPORATION | 2015-10-22 | — | — | US | disclosed |
| US-20150264926-A1 | Corrosive Ingredient(s)-Containing Compositions Having Reduced Toxicity And Method Of Obtaining | S. C. JOHNSON & SON, INC. (US) | 2015-09-24 | — | — | US | disclosed |
| CN-102732062-B | Salt for dye | SUMITOMO CHEMICAL CO., LTD. (JP) | 2015-09-02 | — | — | CN | disclosed |
| EP-2903965-A1 | N-PROP-2-YNYL CARBOXAMIDE DERIVATIVES AND THEIR USE AS TRPA1 ANTAGONISTS | Orion Corporation (FI) | 2015-08-12 | — | — | EP | disclosed |
| CN-103695187-B | Method for improving detergency of detergent composition under high-hardness water quality environment and detergent composition | GUANGZHOU LIBY ENTPR CO LTD | 2015-07-22 | — | — | CN | disclosed |
| WO-2015091931-A1 | OXINDOLE DERIVATIVES CARRYING A PIPERIDYL-SUBSTITUTED AZETIDINYL SUBSTITUENT AND USE THEREOF FOR TREATING VASOPRESSINE-RELATED DISEASES | AbbVie Deutschland GmbH & Co. KG (DE) | 2015-06-25 | — | — | WO | disclosed |
| CN-104685976-A | Conductive pattern fabrication method | TORAY INDUSTRIES | 2015-06-03 | — | — | CN | disclosed |
| US-9028845-B2 | Chimeric immunomodulatory compounds and methods of using the same-IV | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2015-05-12 | — | — | US | disclosed |
| CN-104531383-A | Liquid detergent composition and method for adjusting rheological property of liquid detergent composition | GUANGZHOU LIBY ENTPR CO LTD | 2015-04-22 | — | — | CN | disclosed |
| US-20150065550-A1 | NEW ALPHA2 ADRENOCEPTOR AGONISTS | ORION CORPORATION (FI) | 2015-03-05 | — | — | US | disclosed |
| EP-2834233-A1 | NEW ALPHA2 ADRENOCEPTOR AGONISTS | Orion Corporation (FI) | 2015-02-11 | — | — | EP | disclosed |
| US-20140315197-A1 | MULTIFUNCTIONAL PROBE-PRIMERS | FLUIDIGM CORP (US) | 2014-10-23 | — | — | US | disclosed |
| EP-2176252-B1 | 2, 3-DIHYDROBENZO[1, 4]DIOXIN-2-YLMETHYL DERIVATIVES AS ALPHA2C ANTAGONISTS FOR USE IN THE TREATMENT OF PERIPHERIC AND CENTRAL NERVOUS SYSTEME DISEASES | ORION CORP (FI) | 2014-09-03 | — | — | EP | disclosed |
| CN-104024241-A | Uracil derivatives and their use for medical purposes | DAINIPPON SUMITOMO PHARMA CO | 2014-09-03 | — | — | CN | disclosed |
| CN-102741368-B | Fixer fluid composition and inkjet ink sets including the same | HEWLETT PACKARD DEVELOPMENT CO | 2014-09-03 | — | — | CN | disclosed |
| US-8809536-B2 | 2,3-dihydrobenzo[1,4] dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases | ORION CORPORATION (FI) | 2014-08-19 | — | — | US | disclosed |
| US-20140179926-A1 | 2,3-DIHYDROBENZO[1,4] DIOXIN-2-YLMETHYL DERIVATIVES AS ALPHA2C ANTAGONISTS FOR USE IN THE TREATMENT OF PERIPHERIC AND CENTRAL NERVOUS SYSTEM DISEASES | ORION CORPORATION (FI) | 2014-06-26 | — | — | US | disclosed |
| EP-2423335-B1 | Chimeric immunomodulatory compounds and methods of using the same | DYNAVAX TECH CORP (US) | 2014-05-14 | — | — | EP | disclosed |
| US-20140127255-A1 | CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME-IV | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2014-05-08 | — | — | US | disclosed |
| US-8697723-B2 | 2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases | ORION CORPORATION (FI) | 2014-04-15 | — | — | US | disclosed |
| WO-2014053694-A1 | N-PROP-2-YNYL CARBOXAMIDE DERIVATIVES AND THEIR USE AS TRPA1 ANTAGONISTS | ORION CORPORATION (FI) | 2014-04-10 | — | — | WO | disclosed |
| CN-103695187-A | Method for improving detergency of detergent composition under high-hardness water quality environment and detergent composition | GUANGZHOU LIBY ENTPR CO LTD | 2014-04-02 | — | — | CN | disclosed |
| CN-101842369-B | 2, 3-dihydrobenzo [1,4] dioxin-2-ylmethyl derivatives as alpha 2C antagonists for the treatment of peripheral and central nervous system disorders | ORION CORP | 2014-01-22 | — | — | CN | disclosed |
| US-8597665-B2 | Chimeric immunomodulatory compounds and methods of using the same-IV | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2013-12-03 | — | — | US | disclosed |
| US-20130281486-A1 | 2,3-DIHYDROBENZO(1,4) DIOXIN-2-YLMETHYL DERIVATIVES AS ALPHA2C ANTAGONISTS FOR USE IN THE TREATMENT OF PERIPHERIC AND CENTRAL NERVOUS SYSTEM DISEASES | ORION CORP (FI) | 2013-10-24 | — | — | US | disclosed |
| WO-2013150173-A1 | NEW ALPHA2 ADRENOCEPTOR AGONISTS | ORION CORPORATION (FI) | 2013-10-10 | — | — | WO | disclosed |
| CN-101969920-B | Parakeratosis inhibitor, pore shrinking agent or agent for preventing or improving rough skin, and composition for external use on the skin containing the same | SHISEIDO CO LTD | 2013-09-18 | — | — | CN | disclosed |
| EP-1817318-B1 | STABILIZING METHOD AND STABILIZED COMPOSITION FOR ARYL BORON COMPOUNDS | NIPPON CATALYTIC CHEM IND (JP) | 2013-08-28 | — | — | EP | disclosed |
| US-8492549-B2 | 2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous systeme diseases | ORION CORPORATION (FI) | 2013-07-23 | — | — | US | disclosed |
| CN-101282957-B | New pharmaceutical compounds | ORION CORP | 2013-07-10 | — | — | CN | disclosed |
| EP-1404873-B1 | CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME | DYNAVAX TECH CORP (US) | 2013-05-22 | — | — | EP | disclosed |
| CN-102884145-A | Pre-treatment composition | HEWLETT PACKARD DEVELOPMENT CO | 2013-01-16 | — | — | CN | disclosed |
| US-8318785-B2 | Pharmaceutical compounds | ORION CORPORATION (FI) | 2012-11-27 | — | — | US | disclosed |
| US-20120288857-A1 | MULTIFUNCTIONAL PROBE-PRIMERS | FLUIDIGM CORPORATION (US) | 2012-11-15 | — | — | US | disclosed |
| EP-1781245-B1 | METHOD FOR PERMANENT HAIR PROCESSING | SHOWA DENKO KK (JP) | 2012-11-14 | — | — | EP | disclosed |
| CN-102741368-A | Fixer fluid composition and inkjet ink sets including the same | HEWLETT PACKARD DEVELOPMENT CO | 2012-10-17 | — | — | CN | disclosed |
| CN-102732062-A | Salt for dye | SUMITOMO CHEMICAL CO | 2012-10-17 | — | — | CN | disclosed |
| CN-102731387-A | A salt for dye | SUMITOMO CHEMICAL CO | 2012-10-17 | — | — | CN | disclosed |
| US-20120231039-A1 | CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME-IV | DYNAVAX TECHNOLOGIES CORPORATION | 2012-09-13 | — | — | US | disclosed |
| WO-2012106668-A2 | MULTIFUNCTIONAL PROBE-PRIMERS | FLUIDIGM CORPORATION (US) | 2012-08-09 | — | — | WO | disclosed |
| US-8222398-B2 | Chimeric immunomodulatory compounds and methods of using the same-II | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2012-07-17 | — | — | US | disclosed |
| CN-102442945-A | Compounds and colored photosensitive resin compositions containing the same | SUMITOMO CHEMICAL CO | 2012-05-09 | — | — | CN | disclosed |
| CN-102399184-A | Compound and dye | SUMITOMO CO LTD | 2012-04-04 | — | — | CN | disclosed |
| EP-2423335-A2 | Chimeric immunomodulatory compounds and methods of using the same | Dynavax Technologies Corporation (US) | 2012-02-29 | — | — | EP | disclosed |
| US-8114418-B2 | Chimeric immunomodulatory compounds and methods of using the same—IV | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2012-02-14 | — | — | US | disclosed |
| US-20120035210-A9 | 2,3-DIHYDROBENZO(1,4) DIOXIN-2-YLMETHYL DERIVATIVES AS ALPHA2C ANTAGONISTS FOR USE IN THE TREATMENT OF PERIPHERIC AND CENTRAL NERVOUS SYSTEME DISEASES | ORION CORPORATION (FI) | 2012-02-09 | — | — | US | disclosed |
| CN-102336707-A | Pyridone azo chloro compounds | SUMITOMO CHEMICAL CO | 2012-02-01 | — | — | CN | disclosed |
| CN-102276589-A | Compounds | — | 2011-12-14 | — | — | CN | disclosed |
| US-20110262352-A1 | ARYL PIPERAZINE AND THEIR USE AS ALPHA2C ANTAGONISTS | ORION CORPORATION (FI) | 2011-10-27 | — | — | US | disclosed |
| EP-2364303-A1 | ARYL PIPERAZINE AND THEIR USE AS ALPHA2C ANTAGONISTS | Orion Corporation (FI) | 2011-09-14 | — | — | EP | disclosed |
| CN-102161641-A | Pyridone complex | SUMITOMO CO LTD | 2011-08-24 | — | — | CN | disclosed |
| US-8003115-B2 | Chimeric immunomodulatory compounds and methods of using the same | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2011-08-23 | — | — | US | disclosed |
| CN-102134216-A | Pyridine ketone complex | SUMITOMO CO LTD | 2011-07-27 | — | — | CN | disclosed |
| CN-102134262-A | Pyridine ketone complex | SUMITOMO CO LTD | 2011-07-27 | — | — | CN | disclosed |
| CN-102134217-A | Pyridine ketone complex | SUMITOMO CO LTD | 2011-07-27 | — | — | CN | disclosed |
| CN-102127012-A | Pyridone compound | SUMITOMO CHEMICAL CO | 2011-07-20 | — | — | CN | disclosed |
| CN-102108061-A | Pyridone compound | SUMITOMO CHEMICAL CO | 2011-06-29 | — | — | CN | disclosed |
| CN-102108060-A | Pyridinone compound | SUMITOMO CHEMICAL CO | 2011-06-29 | — | — | CN | disclosed |
| CN-102108062-A | Pyridinone compound | SUMITOMO CHEMICAL CO | 2011-06-29 | — | — | CN | disclosed |
| CN-1809570-B | [1,2,4] triazolo [1,5-a ] pyrimidin-2-ylurea derivatives and uses thereof | NIPPON KAYAKU KK | 2011-06-22 | — | — | CN | disclosed |
| US-20110086852-A2 | PHARMACEUTICAL COMPOUNDS | ORION CORPORATION (FI) | 2011-04-14 | — | — | US | disclosed |
| CN-101969920-A | Parakeratosis inhibitor, pore shrinking agent or agent for preventing or improving rough skin, and composition for external use on the skin containing the same | SHISEIDO CO LTD | 2011-02-09 | — | — | CN | disclosed |
| US-20110004019-A1 | Parakeratosis Inhibitor, Pore-Shrinking Agent, Or Rough Skin Inhibiting/Ameliorating Agent, And External Composition For Skin Containing The Same | SHISEIDO COMPANY LTD. (JP) | 2011-01-06 | — | — | US | disclosed |
| EP-2255780-A1 | PARAKERATOSIS INHIBITOR, PORE SHRINKING AGENT OR AGENT FOR PREVENTING OR IMPROVING ROUGH SKIN, AND COMPOSITION FOR EXTERNAL USE ON THE SKIN CONTAINING THE SAME | Shiseido Company, Ltd. (JP) | 2010-12-01 | — | — | EP | disclosed |
| EP-1910325-B1 | NEW PHARMACEUTICAL COMPOUNDS | ORION CORP (FI) | 2010-10-06 | — | — | EP | disclosed |
| US-7785610-B2 | Chimeric immunomodulatory compounds and methods of using the same—III | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2010-08-31 | — | — | US | disclosed |
| US-20100216836-A1 | 2,3-DIHYDROBENZO(1,4) DIOXIN-2-YLMETHYL DERIVATIVES AS ALPHA2C ANTAGONISTS FOR USE IN THE TREATMENT OF PERIPHERIC AND CENTRAL NERVOUS SYSTEME DISEASES | ORION CORPORATION (FI) | 2010-08-26 | — | — | US | disclosed |
| EP-1400510-B1 | CYCLIC DIAMINE COMPOUNDS HAVING FUSED-RING GROUPS | KOWA CO (JP) | 2010-08-18 | — | — | EP | disclosed |
| WO-2010058060-A1 | ARYL PIPERAZINE AND THEIR USE AS ALPHA2C ANTAGONISTS | ORION CORPORATION (FI) | 2010-05-27 | — | — | WO | disclosed |
| EP-2176252-A1 | 2, 3-DIHYDROBENZO[1, 4]DIOXIN-2-YLMETHYL DERIVATIVES AS ALPHA2C ANTAGONISTS FOR USE IN THE TREATMENT OF PERIPHERIC AND CENTRAL NERVOUS SYSTEME DISEASES | ORION CORPORATION (FI) | 2010-04-21 | — | — | EP | disclosed |
| EP-1400515-B1 | CYCLIC DIAMINE COMPOUND HAVING FIVE-MEMBERED CYCLIC GROUP | KOWA CO (JP) | 2010-04-14 | — | — | EP | disclosed |
| EP-1630165-B1 | [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF | NIPPON KAYAKU KK (JP) | 2010-03-31 | — | — | EP | disclosed |
| WO-2010002940-A2 | HETEROGENEOUS SYNTHESIS OF MULTIVALENT CHIMERIC IMMUNOMODULATORY COMPOUNDS USING PLATFORM BASED MOLECULES | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2010-01-07 | — | — | WO | disclosed |
| US-20090317480-A1 | CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME-II | DYNAVAX TECHNOLOGIES CORPORATION | 2009-12-24 | — | — | US | disclosed |
| US-7625872-B2 | Branched immunomodulatory compounds and methods of using the same | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2009-12-01 | — | — | US | disclosed |
| US-7598244-B2 | [1,2,4]triazolo[1,5,a]pyrimidin-2-ylurea derivative and use thereof | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-10-06 | — | — | US | disclosed |
| US-20090209532-A1 | PHARMACEUTICAL COMPOUNDS | ORION CORPORATION (FI) | 2009-08-20 | — | — | US | disclosed |
| CN-100491355-C | Cyclic diamine compound having five-membered cyclic group | KOWA CO (JP) | 2009-05-27 | — | — | CN | disclosed |
| EP-1404873-A4 | CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME | DYNAVAX TECH CORP (US) | 2009-03-25 | — | — | EP | disclosed |
| WO-2009013390-A1 | 2, 3-DIHYDROBENZO[1, 4] DIOXIN-2-YLMETHYL DERIVATIVES AS ALPHA2C ANTAGONISTS FOR USE IN THE TREATMENT OF PERIPHERIC AND CENTRAL NERVOUS SYSTEME DISEASES | ORION CORPORATION (FI) | 2009-01-29 | — | — | WO | disclosed |
| US-7465728-B2 | Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity | ASTRAZENECA AB (SE) | 2008-12-16 | — | — | US | disclosed |
| CN-101282957-A | New pharmaceutical compounds | ORION CORP (FI) | 2008-10-08 | — | — | CN | disclosed |
| US-20080181909-A1 | Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies | DYNAVAX TECHNOLOGIES CORPORATION | 2008-07-31 | — | — | US | disclosed |
| US-20080154065-A1 | Stabilizing Method and Stabilized Composition for Aryl Boron Compounds | NIPPON SHOKUBAI CO., LTD. (JP) | 2008-06-26 | — | — | US | disclosed |
| EP-1625140-A4 | BRANCHED IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME | DYNAVAX TECH CORP (US) | 2008-06-18 | — | — | EP | disclosed |
| US-20080131389-A1 | Hair Relaxer | SHOWA DENKO K.K. (JP) | 2008-06-05 | — | — | US | disclosed |
| EP-1910325-A2 | NEW PHARMACEUTICAL COMPOUNDS | ORION CORPORATION (FI) | 2008-04-16 | — | — | EP | disclosed |
| US-20080031839-A1 | Agent For Prermanent Hair Processing | SHOWA DENKO K.K. (JP) | 2008-02-07 | — | — | US | disclosed |
| EP-1845940-A1 | HAIR RELAXER | Showa Denko K.K. (JP) | 2007-10-24 | — | — | EP | disclosed |
| EP-1817318-A1 | STABILIZING METHOD AND STABILIZED COMPOSITION FOR ARYL BORON COMPOUNDS | Nippon Shokubai Co.,Ltd. (JP) | 2007-08-15 | — | — | EP | disclosed |
| US-7255868-B2 | Chimeric immunomodulatory compounds and methods of using the same—I | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2007-08-14 | — | — | US | disclosed |
| EP-1781245-A1 | AGENT FOR PERMANENT HAIR PROCESSING | Showa Denko K.K. (JP) | 2007-05-09 | — | — | EP | disclosed |
| US-20070049550-A1 | Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2007-03-01 | — | — | US | disclosed |
| CN-1301297-C | Polyester resin compositions for profile extrusion and profiles made therefrom | TOYO BOSEKI (JP) | 2007-02-21 | — | — | CN | disclosed |
| WO-2007010085-A2 | NEW PHARMACEUTICAL COMPOUNDS | ORION CORPORATION (FI) | 2007-01-25 | — | — | WO | disclosed |
| US-20070010515-A1 | [1,2,4] Triazolo [1,5, a] pyrimidin-2-ylurea derivative and use thereof | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2007-01-11 | — | — | US | disclosed |
| US-7135473-B2 | Cyclic diamine compound with condensed-ring groups | KOWA CO., LTD. (JP) | 2006-11-14 | — | — | US | disclosed |
| CN-1281585-C | Cyclic diamine compounds having fused-ring groups | KOWA CO (JP) | 2006-10-25 | — | — | CN | disclosed |
| WO-2006083031-A1 | HAIR RELAXER | SHOWA DENKO K.K. (JP) | 2006-08-10 | — | — | WO | disclosed |
| WO-2006080538-A1 | STABILIZING METHOD AND STABILIZED COMPOSITION FOR ARYL BORON COMPOUNDS | NIPPON SHOKUBAI CO., LTD. (JP) | 2006-08-03 | — | — | WO | disclosed |
| EP-1630165-A1 | [1,2,4 ]TRIAZOLO [1,5-A]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF | Nippon Kayaku Kabushiki Kaisha (JP) | 2006-03-01 | — | — | EP | disclosed |
| EP-1625140-A2 | BRANCHED IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME | Dynavax Technologies Corporation (US) | 2006-02-15 | — | — | EP | disclosed |
| WO-2006001536-A1 | AGENT FOR PERMANENT HAIR PROCESSING | SHOWA DENKO K.K. (JP) | 2006-01-05 | — | — | WO | disclosed |
| CN-1633468-A | Polyester resin compositions for profile extrusion and profiles made therefrom | TOYO BOSEKI (JP) | 2005-06-29 | — | — | CN | disclosed |
| US-20050131000-A1 | Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity | ASTRAZENECA AB (SE) | 2005-06-16 | — | — | US | disclosed |
| CN-1204176-C | Methods and Compositions | AVECIA LTD (GB) | 2005-06-01 | — | — | CN | disclosed |
| CN-1599717-A | Cyclic diamine compounds having fused-ring groups | KOWA CO (JP) | 2005-03-23 | — | — | CN | disclosed |
| EP-1487823-A1 | DERIVATIVES OF 4-(IMIDAZOL-5-YL)-2-(4-SULFOANILINO)PYRIMIDINE WITH CDK INHIBITORY ACTIVITY | AstraZeneca AB (SE) | 2004-12-22 | — | — | EP | disclosed |
| US-6787570-B2 | ADMINISTERING AN AROMATIC OR HETEROAROMATIC SUBSTITUTED TERTIARYAMINE COMPOUND TO TREAT ATHEROSCLEROSIS, DYSLIPIDEMIA, AND OTHER CORONARY ARTERY DISEASES | PFIZER, INC. | 2004-09-07 | — | — | US | disclosed |
| CN-1522250-A | Cyclic diamine compound having five-membered cyclic group | ������������ʽ���� | 2004-08-18 | — | — | CN | disclosed |
| US-20040136948-A1 | Branched immunomodulatory compounds and methods of using the same | DYNAVAX TECHNOLOGIES CORPORATION | 2004-07-15 | — | — | US | disclosed |
| WO-2004058159-A2 | BRANCHED IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2004-07-15 | — | — | WO | disclosed |
| US-20040132677-A1 | Chimeric immunomodulatory compounds and methods of using the same-IV | DYNAVAX TECHNOLOGIES CORPORATION | 2004-07-08 | — | — | US | disclosed |
| EP-1404873-A2 | CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME | Dynavax Technologies Corporation (US) | 2004-04-07 | — | — | EP | disclosed |
| US-20040058913-A1 | Cyclic diamine compound with condensed-ring groups | KOWA CO., LTD. (JP) | 2004-03-25 | — | — | US | disclosed |
| EP-1400510-A1 | CYCLIC DIAMINE COMPOUNDS HAVING FUSED-RING GROUPS | Kowa Co., Ltd. (JP) | 2004-03-24 | — | — | EP | disclosed |
| EP-1400515-A1 | CYCLIC DIAMINE COMPOUND HAVING FIVE-MEMBERED CYCLIC GROUP | Kowa Co., Ltd. (JP) | 2004-03-24 | — | — | EP | disclosed |
| CN-1468281-A | Method and compositions | — | 2004-01-14 | — | — | CN | disclosed |
| US-20030225016-A1 | Chimeric immunomodulatory compounds and methods of using the same - III | DYNAVAX TECHNOLOGIES CORPORATION | 2003-12-04 | — | — | US | disclosed |
| US-20030199466-A1 | For modulating an immune response | DYNAVAX TECHNOLOGIES CORPORATION | 2003-10-23 | — | — | US | disclosed |
| US-6632810-B2 | Such as N,N'-bis((5,6,7-trimethoxynaphthalen-2-yl)methyl) piperazine, which has inhibitory effects on cell adhesion, for treatment of allergy, asthma, rheumatism, arteriosclerosis, and inflammation | KOWA CO., LTD. (JP) | 2003-10-14 | — | — | US | disclosed |
| US-20030191306-A1 | Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | G.D. SEARLE & CO. (US) | 2003-10-09 | — | — | US | disclosed |
| WO-2003076436-A1 | DERIVATIVES OF 4- (IMIDAZOL-5-YL)-2-(4-SULFOANILINO) PYRIMIDINE WITH CDK INHIBITORY ACTIVITY | ASTRAZENECA AB (SE) | 2003-09-18 | — | — | WO | disclosed |
| US-20030175731-A1 | Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies | DYNAVAX TECHNOLOGIES CORPORATION | 2003-09-18 | — | — | US | disclosed |
| US-20030060461-A1 | Cyclic diamine compound with condensed-ring groups | KOWA CO., LTD. (JP) | 2003-03-27 | — | — | US | disclosed |
| EP-0962445-B1 | Acetylene compound, liquid crystal composition and liquid crystal element | MITSUI CHEMICALS INC (JP) | 2003-02-26 | — | — | EP | disclosed |
| WO-2003000922-A2 | CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2003-01-03 | — | — | WO | disclosed |
| US-6472386-B1 | Cyclic diamine compound with 5-membered ring groups | KOWA CO., LTD. (JP) | 2002-10-29 | — | — | US | disclosed |
| EP-0751133-B1 | Pyrimidine compound, and liquid crystal composition and liquid crystal element using the same | MITSUI CHEMICALS INC (JP) | 2001-09-12 | — | — | EP | disclosed |
| US-20010018446-A1 | Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | G.D. SEARLE & CO. (US) | 2001-08-30 | — | — | US | disclosed |
| EP-1115694-A1 | SUBSTITUTED N-ALIPHATIC-N-AROMATIC (TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | Monsanto Company (US) | 2001-07-18 | — | — | EP | disclosed |
| US-6217793-B1 | Acetylene compound, liquid crystal composition and liquid crystal element | MITSUI CHEMICALS, INC. (JP) | 2001-04-17 | — | — | US | disclosed |
| WO-2000018723-A1 | SUBSTITUTED N-ALIPHATIC-N-AROMATIC TERTIARY-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | MONSANTO COMPANY (US) | 2000-04-06 | — | — | WO | disclosed |
| US-6017676-A | Photoresist composition comprising a copolymer resin | HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) | 2000-01-25 | — | — | US | disclosed |
| EP-0962445-A1 | Acetylene compound, liquid crystal composition and liquid crystal element | Mitsui Chemicals, Inc. (JP) | 1999-12-08 | — | — | EP | disclosed |
| US-5770108-A | HIGH SPEED RESPONSE, MOLECULAR ORIENTATION, HIGH CONTRAST, RECEPTIVITY | MITSUI TOATSU CHEMICALS, INC. (JP) | 1998-06-23 | — | — | US | disclosed |
| EP-0468293-B1 | Metallic water borne base coat composition based on acrylic latex resins using a water reducible resin for aluminium storage and a hectorite clay for rheology control | BASF CORP (US) | 1997-09-24 | — | — | EP | disclosed |
| EP-0471972-B1 | Metallic water borne base coat composition | BASF CORP (US) | 1997-03-26 | — | — | EP | disclosed |
| EP-0628026-B1 | CYANO-OXIME ETHERS, PROCESS FOR PRODUCING THEM, AGENTS CONTAINING THEM AND THEIR USE | BASF AG (DE) | 1997-01-22 | — | — | EP | disclosed |
| EP-0751133-A1 | Pyrimidine compound, and liquid crystal composition and liquid crystal element using the same | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1997-01-02 | — | — | EP | disclosed |
| EP-0498179-B1 | Cyclopropancarboxylic acid amides and thioamides, process and intermediates for their preparation and their use as pesticides | BASF AG (DE) | 1996-09-25 | — | — | EP | disclosed |
| US-5401768-A | Prostaglandin derivative, antiulcer, hypotensive, anticoagulant | TORAY INDUSTRIES, INC. (JP) | 1995-03-28 | — | — | US | disclosed |
| EP-0628026-A1 | CYANO-OXIME ETHERS, PROCESS FOR PRODUCING THEM, AGENTS CONTAINING THEM AND THEIR USE. | BASF AG (DE) | 1994-12-14 | — | — | EP | disclosed |
| CN-1025185-C | Phenoxyalryl carboxylic acid derivatives and process for their preparations | KYORIN SEIYAKU KK (JP) | 1994-06-29 | — | — | CN | disclosed |
| EP-0399427-B1 | Metallic water borne base coat of improved stability and appearance | BASF CORP (US) | 1994-02-02 | — | — | EP | disclosed |
| EP-0365678-B1 | 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLENE PGI 2 DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND USE THEREOF | TORAY INDUSTRIES (JP) | 1994-01-05 | — | — | EP | disclosed |
| EP-0389162-B1 | 2,5,6,7-Tetranor-4,8-inter-m-phenylene PGI2 derivatives | TORAY INDUSTRIES (JP) | 1993-12-08 | — | — | EP | disclosed |
| WO-1993016985-A1 | CYANO-OXIME ETHERS, PROCESS FOR PRODUCING THEM, AGENTS CONTAINING THEM AND THEIR USE | BASF AKTIENGESELLSCHAFT (DE) | 1993-09-02 | — | — | WO | disclosed |
| US-5221684-A | Insecticides, nematocides, miticides | BASF AKTIENGESELLSCHAFT (DE) | 1993-06-22 | — | — | US | disclosed |
| US-5204401-A | Metallic water borne base coat composition based on acrylic latex resins using acrylic resins derived from vinyl monomers having nonionic and urethane functionality for aluminum storage and a treated hextorie clay for rheology control - water base 9 | BASF CORPORATION (US) | 1993-04-20 | — | — | US | disclosed |
| EP-0318032-B1 | THERMAL DYE TRANSFER SHEET | MITSUBISHI KASEI CORPORATION (JP) | 1993-04-14 | — | — | EP | disclosed |
| US-5190963-A | Pesticides, crop protection | BASF AKTIENGESELLSCHAFT (DE) | 1993-03-02 | — | — | US | disclosed |
| US-5168105-A | Metallic water borne base coat composition based on acrylic latex resins using an acrylic resin having acid and nonionic functionality for aluminum storage and a treated hetorite clay for rheology control-water base 5 | BASF CORPORATION (US) | 1992-12-01 | — | — | US | disclosed |
| US-5166255-A | Nonionic surfactants and acid monomers | BASF CORPORATION (US) | 1992-11-24 | — | — | US | disclosed |
| EP-0498179-A1 | Cyclopropancarboxylic acid amides and thioamides, process and intermediates for their preparation and their use as pesticides | BASF Aktiengesellschaft (DE) | 1992-08-12 | — | — | EP | disclosed |
| EP-0486804-A2 | Hydroquinonediethers, processes for their preparation, and their use in combatting pests | BASF Aktiengesellschaft (DE) | 1992-05-27 | — | — | EP | disclosed |
| EP-0471972-A2 | Metallic water borne base coat composition | BASF Corporation (US) | 1992-02-26 | — | — | EP | disclosed |
| US-5086071-A | Improved chemical stability and ppotent in vivo | TORAY INDUSTRIES, INC. (JP) | 1992-02-04 | — | — | US | disclosed |
| EP-0468293-A1 | Metallic water borne base coat composition based on acrylic latex resins using a water reducible resin for aluminium storage and a hectorite clay for rheology control | BASF Corporation (US) | 1992-01-29 | — | — | EP | disclosed |
| EP-0318034-B1 | THERMAL DYE TRANSFER SHEET | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1992-01-29 | — | — | EP | disclosed |
| US-5068334-A | Analgesics and antipyretics | KARL THOMAE GMBH (DE) | 1991-11-26 | — | — | US | disclosed |
| US-4988666-A | COPIES, YELLOW QUINOLINE DYE DISPERSED ON A MULTILAYER ELEMENT | MITSUBISHI KASEI CORPORATION (JP) | 1991-01-29 | — | — | US | disclosed |
| EP-0399427-A1 | Metallic water borne base coat of improved stability and appearance | BASF Corporation (US) | 1990-11-28 | — | — | EP | disclosed |
| EP-0232776-B1 | 2,5,6,7-TETRANOR-4,8-INTER-M-PHENYLENE PGI2 DERIVATIVES | TORAY INDUSTRIES, INC. (JP) | 1990-10-24 | — | — | EP | disclosed |
| EP-0389162-A1 | 2,5,6,7-Tetranor-4,8-inter-m-phenylene PGI2 derivatives | TORAY INDUSTRIES, INC. (JP) | 1990-09-26 | — | — | EP | disclosed |
| US-4954478-A | Magenta dye dispersed in binder; colorfastness | MATSUSHITA ELECTRIC INDUSTRIAL CO. LTD. (JP) | 1990-09-04 | — | — | US | disclosed |
| EP-0379132-A2 | Cephalosporin derivatives and process for their preparation | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-07-25 | — | — | EP | disclosed |
| EP-0365678-A1 | 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLENE PGI 2 DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND USE THEREOF | TORAY INDUSTRIES, INC. (JP) | 1990-05-02 | — | — | EP | disclosed |
| EP-0338228-A2 | Use of quinoline-2,5-diones in a medicament having an analgesic, antipyretic and/or antiphlogistic activity | Dr. Karl Thomae GmbH (DE) | 1989-10-25 | — | — | EP | disclosed |
| EP-0318032-A2 | Thermal dye transfer sheet | MITSUBISHI KASEI CORPORATION (JP) | 1989-05-31 | — | — | EP | disclosed |
| EP-0318034-A1 | Thermal dye transfer sheet | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1989-05-31 | — | — | EP | disclosed |
| US-4820685-A | COLOR LAYER OF QUINOLINE DYES AND BINDERS, ON FILM BASE | MITSUBISHI KASEI CORPORATION (JP) | 1989-04-11 | — | — | US | disclosed |
| CN-1032003-A | Phenoxyalkylcarboxylacid acid derivatives and preparation method thereof | KYORIN SEIYAKU KK (JP) | 1989-03-29 | — | — | CN | disclosed |
| US-4775692-A | ANTILIPEMIC, ANTICOAGULANT, HYPOTENSIVE, ANTISECRETORY AND ANTIULCER AGENT | TORAY INDUSTRIES, INC. (JP) | 1988-10-04 | — | — | US | disclosed |
| EP-0232776-A2 | 2,5,6,7-tetranor-4,8-inter-m-phenylene PGI2 derivatives | TORAY INDUSTRIES, INC. (JP) | 1987-08-19 | — | — | EP | disclosed |
| EP-0232776-A2 | 2,5,6,7-tetranor-4,8-inter-m-phenylene PGI2 derivatives | TORAY INDUSTRIES, INC. (JP) | 1987-08-19 | — | — | EP | disclosed |